Virtual ETHICS Int'l Pharma & Med Device Ethics & Compliance Congress Features Annual Medical Device Roundtable

Virtual ETHICS Int'l Pharma & Med Device Ethics & Compliance Congress Features Annual Medical Device Roundtable

Virtual Online Video Event Live and 6 Months Access to Video Archive

Sponsored by ETHICS, the International Society of Healthcare Compliance Professionals

Media Partners: Policy & Medicine Compliance Update

June 14-17, 2021

www.InternationalPharmaCongress.com

PRESS RELEASE
Phone: 800-503-8171
Email: registration@hcconferences.com
Website: www.InternationalPharmaCongress.com

NEW REGISTRATION RATES FOR A VIRTUAL AGE

Early bird registration discounts now available with special ETHICS/EFPIA/FSA/IFPMA/MedTech Europe/PCF rates. Rates are up to €1,000 less than major competing events.
- Click Here -

FEATURING THE ANNUAL MEDICAL DEVICE ETHICS & COMPLIANCE ROUNDTABLE

Aline Lautenberg, LLM
General Counsel, Director Legal & Compliance, MedTech Europe, Brussels, Belgium

Anthony McQuillan, LLB
Vice President Legal & Compliance EMEA, Medtronic International; Former Senior Attorney EMEA, Hewlett-Packard; London, UK

Tamara Tubin
International Compliance Director, Corporate Compliance, Wright Medical Group N.V., Vice Chair, Ethics & Compliance Committee, MedTech Europe, Member, Strategic Committee, ETHICS, Zürich, Switzerland

Roeland Van Aelst
Regional Lead Third Party Intermediary Ethics & Compliance EMEA, Johnson & Johnson, President, International Society of Healthcare Ethics and Compliance Professionals (ETHICS),Chairman, MedTech Europe Code Committee, Brussels, Belgium

Christopher L. White, JD
Chief Operating Officer & General Counsel, Advanced Medical Technology Association (AdvaMed), Washington, DC, USA

PARIS, FRANCE -- PHARMA UPDATE NEWS SERVICE™ -- FEBRUARY 25, 2021: The Virtual Fourteenth International Pharmaceutical and Medical Device Ethics and Compliance Congress, www.InternationalPharmaCongress.com, has been rescheduled to June 14 - 17, 2021, will take place in the form of online video broadcast which will be offered live and archived for 6 months following the live broadcast.

KEYNOTE SPEAKERS

Hani Abouhalka, MBA Company Group Chairman, Medical Devices EMEA, Johnson & Johnson, New Brunswick, NJ, USA	Gemma Aiolfi Head of Compliance, Corporate Governance and Collective Action, Basel Institute on Governance; Former Advisor, Working Group on Bribery in International Business Transactions, OECD; Basel, Switzerland
Pedro Carrascal, MBA President, European Multiple Sclerosis Platform (EMSP), Chief Executive Officer, EME (Multiple Sclerosis Spain), Biscay MS Society and MS Basque Foundation, Board, Multiple Sclerosis International Federation (MSIF), Bilbao, Spain	Roxana Family, Thèse de Doctorat Droit Vice-President, Chair in Law & Business Ethics and Program Director, Cergy Pontoise University, Cergy-Pontoise, France
Robert I. Dodge, JD Assistant Director, FCPA Unit, US Securities & Exchange Commission; Former Assistant U.S. Attorney, US Attorney's Office, Western District of Michigan; Former Assistant Section Chief, Environmental Defense Section, US Department of Justice, Washington, DC, USA	David Fuhr, JD Assistant Chief, FCPA Unit, Fraud Section, Criminal Division, US Department of Justice, Washington, DC, USA

Kirt Kraeuter, MGA Senior Director, Corporate Compliance, Moderna; Former European Compliance Director, Otsuka; Former, Executive Director, Worldwide Compliance Committee & Monitoring, Bristol-Myers Squibb; Yardley, PA, USA	Sally Molloy, JD Chief, Strategy, Policy & Training Unit, Fraud Section; Former Assistant U.S. Attorney, US Attorney's Office, Northern District of Georgia, US Department of Justice; Washington, DC, USA
Piergiorgio Pepe, MA EU Law, President, Quantum Ethics, Ethics and Compliance Lecturer, SciencesPo; Former Compliance Director Western Europe & Canada, AbbVie; Former Director, Compliance & Ethics EMEA, Bristol-Myers Squibb; Paris, France	N. Craig Smith Chaired Professor of Ethics and Social Responsibility, Academic Director of ESRI (the INSEAD Ethics and Social Responsibility Initiative), and Programme Director for the Healthcare Compliance, Implementation Leadership Programme, INSEAD, Fontainebleau, France

FEATURED FACULTY

Imelda Álvarez, LLB, MBA Chief Executive Officer, Comply Latam, SC; Former Regional Integrity & Compliance Head Latin America and Canada, Novartis; Mexico City, Mexico	Ghadeer Alyacoub, MSc Regional Head Healthcare Compliance Europe, Middle East and Africa Medical Devices, Johnson & Johnson, Dubai, UAE	Bas Amesz, MSc Partner, Vintura, Baarn, Utrecht, Netherlands
Michael Bartke, PhD Director Ethics & Compliance, Alexion, Former Director Compliance Management, Daiichi Sankyo Europe GmbH, Strategic Committee, ETHICS, Munich, Germany	Ann Beasley, JD Chief Compliance Officer, Zai Lab; Former Senior Vice President, Chief Compliance Officer, Biogen; Former Global Compliance Office, Novartis Pharma AG; Boston, MA, USA	Duygu Beyazo, LLB Senior Associate, NSN Law Firm; Former Compliance Manager (Secondment), Business Conduct, Gilead Sciences; Istanbul, Turkey
Stefano Biondi, LLB, PhD Compliance Manager and Group Data Protection Officer, Menarini Group, Florence, Italy	Richard Bistrong, MA Chief Executive Officer, Front-Line Anti-Bribery LLC Contributing Editor, FCPA Blog; Former Confidential Human Source (CHS) and Cooperating Witness, FBI and US DOJ; New York, NY, USA	Eric Bolesh Chief Operating Officer, Cutting Edge Information, Raleigh-Durham, NC, USA
Keith Burn Global Investigations Director, Ipsen; Former Associate Investigator, Parliamentary and Health Service Ombudsman, NHS; Former Detective Constable, London Metropolitan Police; Slough, UK	Zachary N. Coseglia, JD Managing Principal and Health of Innovation, R&G Insights Lab, Boston, MA	Rika De Ville Vice President Global Compliance & Privacy, Data Protection Officer, Perrigo Company plc Nazareth, Belgium
Anisa Dhalla Global Chief Compliance Officer, UCB, Inc., Atlanta, GA, USA	Holger Diener Healthcare Compliance Officer, Janssen-Cilag GmbH, Johnson & Johnson; Former Managing Director, Association of Voluntary Self-Regulation for the Pharmaceutical Industry (“FSA”);Berlin, Germany	Kalwant Dhindsa, CIPP/E, CCEP Compliance Director, Convatec; Former Senior Corporate Compliance Counsel, Bayer; Reading, UK
Laetitia Ducroquet Vice-President, Global Business Ethics, Ipsen, Boulogne Billancourt, France	Julien Durand, MBA, PhD Vice President, Head of Transformation, Global Ethics & Compliance, Takeda Chair, Future Health Technologies & Bioethics Working Groups, IFPMA; Zürich, Switzerland	Signe Elbæk, JD, LLM Former Group Chief Compliance Officer, Coloplast; Former Vice Chair, Ethics and Compliance Committee and Member of the Code Committee, MedTech Europe; Former Compliance Manager, Attorney, Dako Denmark A/S; Copenhagen, Denmark
Jacob Elberg, JD Associate Professor, Seton Hall University School of Law; Former Chief, Health Care & Government Fraud Unit, and Assistant US Attorney US Attorney's Office, District of New Jersey; Newark, NJ, USA	Robert Ennis, JD, LLM Vice President and Lead Compliance Counsel, Pfizer, New York, NY	Alex Fell Head, Ethics, Compliance and DPO International, Amicus Therapeutics; Former Vice President, Global Ethics and Compliance, Head of Strategy, Planning and Operations, GSK; London, UK
George Fife Partner, Forensic & Integrity Services, EY, Former Executive Director, Compliance & Ethics, Bristol-Myers Squibb, Paris, France	Indrani M. Lall Franchini, JD Executive Vice President & Chief Compliance Officer, Alexion Pharmaceuticals, Inc.; Former Assistant General Counsel, Pfizer; New York, NY, USA	Sylvie Gallage-Alwis, DEA, LLM Partner, Signature Litigation Avocat à la Cour Solicitor in England & Wales Committees Vice Chair, International Association of Defense Counsel, Paris, France
Abhiroop Gandhi Trust and Compliance Officer, Verily Life Sciences (an Alphabet company), Former Vice President, Corporate Compliance, Mallinckrodt, San Francisco, CA, USA	Gary F. Giampetruzzi, Esq. Partner, Paul Hastings, Former Vice President and Assistant General Counsel, Head of Government Investigations, Pfizer Inc., New York, NY, USA	Tom Gregory Partner, Fraud Investigation & Dispute Services, Ernst & Young, LLP, Atlanta, GA
Ulf H. Grundmann Partner, FDA and Life Sciences, King & Spalding LLP, Frankfurt am Main, Germany	Joseph W. Henein, PharmD President and Chief Executive Officer, NewBridge Pharmaceuticals, Dubai, UAE	Bella Rafael Hovhannisyan Acting Chief Compliance Officer, Business Integrity Lead, Intercontinental, CSL Bering; Former Compliance & Ethics Lead, Spain & Portugal, Russia & Turkey, Bristol-Myers Squibb; Berne, Switzerland
Mirgen Jaku, MA Lead of Market Readiness, Digital Surgery, EMEA, Johnson & Johnson, Hamburg, Germany	Franziska Janorschke Global Head, Business Practices Office, Novartis International AG, Basel, Switzerland	Els Janssens, LLM Associate, Baker & McKenzie; Former Legal Adviser, European Medicines Agency; Former Senior Legal Counsel, Johnson & Johnson; Brussels, Belgium
Larisa K. Jasnic, LLB, LLM Head of Ethics & Compliance, International, Alnylam Pharmaceuticals; Former Regional Compliance Officer, Region Europe, Novartis; Zug, Switzerland	Elisabeth Kohoutek Senior Associate, FDA and Life Sciences, King & Spalding LLP, Frankfurt am Main, Germany	Keith Korenchuk, MPH, JD Vice President and Chief Compliance Officer, DH Diagnostics, a Danaher Company, Chevy Chase, MD, USA
Iordanis Kerenidis, PhD Director, Paris Centre for Quantum Computing (PCQC) CNRS Senior Researcher (DR2), Algorithms and Complexity Group IRIF, University Paris Diderot, Paris, France	Adem Koyuncu, MD, PhD (Law) Partner and Chair, Food, Drug & Device Practice Group, Covington; Brussels, Belgium & Frankfurt, Germany	Tomasz Kruk Head of Compliance, Vifor Pharma, Former Director International Compliance, Mallinckrodt Pharmaceuticals; Former Director Global Ethics & Compliance, Actavis plc (now Allergan); Zurich, Switzerland
Aline Lautenberg, LLM General Counsel, Director Legal & Compliance, MedTech Europe, Brussels, Belgium	Lei Li, LLM Managing Partner, Beijing and Shanghai Offices, Sidley Austin; Former Third Secretary, Ministry of Commmerce, People's Republic of China, Beijing, China; Beijing, China	Rosa Magistri, CIPP/E Head of Legal and Compliance Europe, SeaGen International GmbH; Former Regional Director Office of Ethics and Compliance, Western Europe & Canada, Region South & Israel, AbbVie; Former Associate Compliance Director, Shire; Zug, Switzerland
Sofie Melis Director HR and Ethics & Compliance, International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), Geneva, Switzerland	Anthony McQuillan, LLB Vice President Legal & Compliance EMEA, Medtronic International; Former Senior Attorney EMEA, Hewlett-Packard; London, UK	Philippa Montgomerie, CPE, LLB Vice President EMEA Compliance and Global Programs, Medtronic Limited, Watford, UK
Arthur Muratyan, Esq. Secretary General, International Society of HealthCare, Ethics and Compliance Professionals (ETHICS), Chair, MedTech Compliance Panel; Former VP-Head of Legal Corporate and Global Compliance Officer, Sanofi	Laura Nassar, PharmD Head of Compliance Middle East, Roche Pharmaceuticals, Chair, Compliance Committee, Pharmaceutical Research, and Manufacturers Association, Gulf (PhRMAG), Beirut, Lebanon	Gina Nese, JD Vice President Global Compliance and Ethics Officer, Align Technology; Former Chief Compliance Officer, Advanced Sterilization Products; Bellevue, WA, USA
Lauri Q. Opar Head, Enterprise Risk Management & Risk Analytics, Global Ethics & Compliance, Glaxosmithkline, Brentford, Middlesex, UK	Giota Papamarkou Vice-President, Business Ethics Global, France, Ipsen; Former EMEA Compliance and Ethics Manager, Bristol-Myers Squibb; Paris, France	Mario Prohasky Principal, EMEA Compliance Consulting, IQVIA, London, UK
Ariadna Quesada, MSJ Compliance Director Europe and MEATI, Hillrom; Former Law, Ethics and Compliance Officer, The Netherlands, AbbVie; Former Compliance Manager International, MicroPort Orthopedics; Amsterdam, Netherlands	Amanda N. Raad, JD Co-lead, Anti-Corruption and International Risk, Ropes & Gray, London, UK	Nadege Rochel Global Compliance Manager, Holister Incorporated, Milan, Italy
Christian-Claus Roth Head Scientific Engagement Governance, Novartis, Co-president, International Pharmaceutical Congress Advisory Association (IPCAA), Member, Ethics and Business Integrity Committee, IFPMA, Basel, Switzerland	Giuseppe Saporito, LLM Global Legal & Regulatory Expert, IQVIA, Milan, Italy	Leonardo Silva, LLM Global Compliance Officer, Head of Global Compliance, Ferring, Former Head of Compliance, Acino Group, Former Compliance Director, Emerging Markets, Takeda, St. Prex, Switzerland
Tiffany Tang Associate Principal, Global Consulting, IQVIA; Former Senior Manager, Ethics and Compliance, Novo Nordisk; New York, NY	Madina Torchinova Vice President, Head Global Compliance, MorphoSys; Former Regional Head of Compliance, Central & Eastern Europe, Middle East & Africa, and Global OTC, Sandoz; Munich, Germany	Tamara Tubin International Compliance Director, Corporate Compliance, Wright Medical Group N.V., Vice Chair, Ethics & Compliance Committee, MedTech Europe, Member, Strategic Committee, ETHICS, Zürich, Switzerland
Samar Wakim, PharmD Ethics & Compliance Head MEA, Innovative Medicines, Novartis Pharma Services AG, Dubai, UAE	Christopher L. White, JD Chief Operating Officer & General Counsel, Advanced Medical Technology Association (AdvaMed), Washington, DC, USA	Mariusz Witalis Partner, Forensic & Integrity Services, EY, Warsaw, Poland

CO CHAIRS

Anne-Sophie Bricca, MA, DEA International Law, DES European law
Deputy General Counsel & Senior Director Legal Affairs & Compliance, Terumo BCT; Chair, Ethics and Compliance Group and seats at the Code Committee, MedTech Europe; Brussels, Belgium

Stephen Nguyen Duc
Vice-President, Global Head of Human Resources and Ethics & Compliance, Medday Pharmaceuticals; Board Member, Strategic Committee International Society of Healthcare Ethics and Compliance Professionals (ETHICS); Paris, France

Dominique Laymand, Esq.
Executive Vice President, Chief Ethics & Social Responsibility Officer, Ipsen; Honorary President, International Society of Healthcare Ethics and Compliance Professionals (ETHICS); Paris, France

SPONSORED BY:

GRANTORS

GOLD

SILVER

BRONZE

MEDIA PARTNER:

STAY CONNECTED

Tweet using #PharmaCongress

CONGRESS HIGHLIGHTS

New content, optimized for online learning, focused on new regulatory developments and managing ethics and compliance programs during the COVID 19 pandemic

Engage with faculty through polling, Q&A sessions, chat and direct video messaging

Network in real time with other attendees through direct attendee to attendee and group video messaging

Live and curated sessions streamed directly to you through our easy to navigate virtual platform

Access to an extensive video archive of past Congress presentations providing a context for the evolution of the compliance professions and the legal and regulatory setting

Virtual exhibit hall featuring innovative solutions, products and services with opportunity to directly contact exhibitors for further information

PAST GLOBAL PHARMA COMPLIANCE CONGRESSES

2007 - Brussels

2008 - Paris

2009 - Rome

2010 - Berlin

2011 - Istanbul

2011 - Singapore

2012 - Budapest

2012 - Shanghai

2012 - São Paulo

2013 - Madrid

2013 - Kuala Lumpur

2014 - Dubai

2014 - Mexico City

2014 - Shanghai

2015 - Manila

2016 - Warsaw

2017 - Lisbon

2018 - Vienna

2019 - Athens

FEATURING THE INTERNATIONAL CONGRESS ADVANCED VIRTUAL STREAMING PLATFORM

2021 GLOBAL PHARMA/MED DEVICE ETHICS & COMPLIANCE CONGRESSES

VIRTUAL FOURTEENTH INTERNATIONAL PHARMACEUTICAL AND MEDICAL DEVICE ETHICS & COMPLIANCE CONGRESS

Virtual Online Video Event Live and Archived
Sponsored by International Society of Healthcare Compliance Professionals (ETHICS)
Media Partner: Policy & Medicine Compliance Update
June 14-17, 2021
www.International PharmaCongress.com

VIRTUAL TWENTY-SECOND ANNUAL PHARMACEUTICAL AND MEDICAL DEVICE ETHICS & COMPLIANCE CONGRESS

Virtual Online Video Event Live and Archived
Sponsored by Pharmaceutical Compliance Forum
Media Partners: Harvard Health Policy Review, Health Affairs and Policy & Medicine Compliance Update
November, 2021
www.PharmaCongress.com

CONGRESS REGISTRATION

For Congress registration information, visit www.internationalpharmacongress.com/registration/, email registration@hcconferences.com, or call 800-503-8171.

CONGRESS EXHIBIT & SPONSORSHIP INFORMATION

For sponsorship and exhibit information, visit or contact Suzanne Tyler, Exhibit Manager, at (206) 244-4861 phone, (206) 319-5303 fax, or exhibits@hcconferences.com.